VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 174 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $671,943 | -0.9% | 101,964 | +2.1% | 0.01% | 0.0% |
| Q1 2023 | $678,131 | -12.0% | 99,872 | -4.2% | 0.01% | -16.7% |
| Q4 2022 | $770,600 | +74715.5% | 104,276 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $1,030 | -99.9% | 104,276 | 0.0% | 0.01% | -10.0% |
| Q2 2022 | $1,137,000 | -3.6% | 104,276 | 0.0% | 0.01% | +42.9% |
| Q1 2022 | $1,179,000 | -33.8% | 104,276 | -8.2% | 0.01% | -30.0% |
| Q4 2021 | $1,781,000 | -8.5% | 113,536 | 0.0% | 0.01% | -9.1% |
| Q3 2021 | $1,946,000 | -20.3% | 113,536 | 0.0% | 0.01% | -26.7% |
| Q2 2021 | $2,442,000 | +9.2% | 113,536 | -23.8% | 0.02% | +7.1% |
| Q1 2021 | $2,237,000 | +40.4% | 148,956 | +22.8% | 0.01% | +16.7% |
| Q4 2020 | $1,593,000 | +1.7% | 121,256 | -25.2% | 0.01% | -7.7% |
| Q3 2020 | $1,567,000 | +13.0% | 162,214 | +33.8% | 0.01% | 0.0% |
| Q2 2020 | $1,387,000 | +12.0% | 121,256 | +1.5% | 0.01% | -7.1% |
| Q1 2020 | $1,238,000 | -36.8% | 119,456 | 0.0% | 0.01% | +16.7% |
| Q4 2019 | $1,960,000 | +9.0% | 119,456 | -11.7% | 0.01% | 0.0% |
| Q3 2019 | $1,798,000 | +9.2% | 135,356 | +15.9% | 0.01% | -7.7% |
| Q2 2019 | $1,646,000 | +85.6% | 116,800 | +142.3% | 0.01% | +62.5% |
| Q1 2019 | $887,000 | -26.0% | 48,200 | +5.0% | 0.01% | -20.0% |
| Q4 2018 | $1,199,000 | +43.6% | 45,900 | +26.1% | 0.01% | +66.7% |
| Q3 2018 | $835,000 | – | 36,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |